On June 8, the Chongqing Municipal Health Insurance Bureau issued the "Public ity on the list of medical insurance Class B drugs that are gradually digested by the local level in Chongqing", and published the list of local medical insurance liquidation varieties in Chongqing within three years.
The documents show that, in the light of the actual situation in Chongqing, the Chongqing Municipal Health Insurance Bureau has clarified the three-year digestion principle of the local supplementary type B drugsIncluding: drugs belonging to the national medical insurance catalog to remove varieties and no state drug regulatory approval, will no longer be included in the municipal medical insurance reimbursement from January 1, 2020;
According to the list, a total of 405 drugs were "digested" within three years of the proposed requirementAccording to the digestive schedule, the first year of digestion of drugs, from January 1, 2021 to stop medical insurance reimbursement, the second year of digestion of drugs, from January 1, 2022, the third year of medical treatment, from July 1, 2022 to stop medical insurance reimbursement.
In fact, in addition to Chongqing, many places have issued the gradual digestion of local supplementary health insurance Class B drugs documentsFor example, on June 4, Guangxi Medical Insurance Bureau issued a notice, in accordance with the 2019 version of the national health insurance catalog adjustment rules, is now 44 traditional Chinese medicine and 148 Western medicine from June 1 out of the province's medical insurance directory, the original Guangxi medical insurance drug payment within the prescribed increase in the provisions of the drug gradually digested within three years.
At the end of 2019, The Hunan Provincial Health Insurance Bureau and the Ministry of Human Resources and Social Security jointly issued the Notice on Effective Implementation, which requires strict implementation of the National Drug Catalog and the digestion of the original increase in drugs year by year.
Anhui Province has also issued a notice, in the next three years in accordance with the 4:4:2 model of the gradual digestion of local supplementary drugsThe specific time is: January 1 - December 31, 2020, to complete the first batch of 40% of the digestion tasks, January 1 - December 31, 2021, to complete the second batch of 40% of the digestion tasks, January 1, 2022 to December 31, to complete the remaining 20% of the digestion tasks, january 2023, the official implementation of the national unified catalogue.
In addition to Chongqing, Guangxi, Hunan and Anhui provinces, Guangdong, Tianjin, Zhejiang and other places have also been issued, to carry out provincial directory and the new version of the national health insurance directory docking workAccording to incomplete statistics, so far, more than 10 provinces and cities have adjusted the local health insurance directory.
According to the plan of the State Health Insurance Administration, all varieties of the key monitoring catalogue issued by the Health and Care Commission should be removed in the local medical insurance directory firstAt the same time, despite the development of a three-year digestion programme for additional varieties, and the completion of the digestion of 40 per cent of provincial-level supplementary varietiesAlthough there are still some areas have not clearly cleaned up the local addition strains, but you can see that the local health insurance catalog adjustment action has begun, which means that the local supplementary health insurance varieties digestion will accelerate.
The industry believes that in this context, the medical market drug pattern or affected by some changes Despite the three-year buffer period for local catalog adjustments, the relevant pharmaceutical companies can only win in the future pharmaceutical market if they constantly adjust their marketing strategies to promote consistency evaluation or focus on research and development innovation.